Is BHC stock a Buy, Sell, or Hold?

Based on our analysis, BHC is currently a HOLD with low confidence. 📊 HOLD: BHC shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

What is the fair value of BHC stock?

Our analysis estimates the fair value range for BHC to be between $5.43 and $5.77. The current price is $5.42.

What is the analyst price target for BHC?

The average Wall Street analyst price target for BHC is $7.57. This implies a potential upside of 39.7% from current levels.

BHC Stock Analysis: Buy, Sell, or Hold?

BHC - Bausch Health Companies Inc

PHARMACEUTICAL PREPARATIONS

$5.42

-0.03 (-0.55%) ▼

5d: -5.74%

30d: -6.87%

90d: -9.52%

HOLD

LOW Confidence

Protect Your BHC Gains

Analysis Updated: May 15, 2026 12:00 AM ET

Earnings: Apr 29, 2026 0d

Smart Money Accumulation

BHC is down 5.7% this week, but smart money is accumulating calls. Top strike: $7 2026-07-17 with 5,004 OI. Call ratio: 67% View Scanner →

Strength: 4.5/10

Get Alerted When BHC Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 HOLD: BHC shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: -6.2%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$5.74

Based on -1.1% avg growth

INTRINSIC VALUE TODAY

$3.57

Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 1.5x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: BHC is currently trading at $5.42, which is considered slightly low relative to its 30-day fair value range of $5.43 to $5.77. From a valuation perspective, the stock is trading at a discount (Forward PE: 1.3) compared to its historical average (1.5). Remarkably, the market is currently pricing in an annual earnings decline of 3.0% over the next few years. This pessimistic expectation contrasts with the company's recent 1368.0% earnings growth, suggesting potential undervaluation if the company simply maintains stability.

Technical Outlook: Technically, BHC is in a strong uptrend. Immediate support is located at $5.25, while resistance sits at $5.89.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.57 (+39.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position SLIGHTLY LOW

Historical Trading Range $5.43 - $5.77

Company Quality Score 62/100 (BUY)

Volume Confirmation HIGH

Confidence Score 79.5%

Protect Your Profits

Holding BHC? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BULLISH: Price oversold vs 30-day range
NEUTRAL: Mixed technical signals (40/100)
BULLISH: High volume confirmation
BULLISH: Trading 39.7% below Wall St target ($7.57)
CAUTION: Recommendation downgraded due to -5.7% 5-day decline

Trading Range Analysis

30-Day Trading Range $5.43 - $5.77

Current vs Trading Range SLIGHTLY LOW

Support & Resistance Levels

Support Level $5.25

Resistance Level $5.89

Current Trend Strong Uptrend

Technical data as of May 15, 2026

Fundamental Context

Forward P/E (Next Year Est.) 1.34

Wall Street Target $7.57 (+39.7%)

Revenue Growth (YoY) 11.7%

Earnings Growth (YoY) 1368.0%

Profit Margin -11.5%

Valuation Discount vs History -3.0% cheaper

PE vs Historical 1.3 vs 1.5 CHEAP

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): -3.0% (market-implied from PE analysis)

1-Year Target $5.26 (-3%)

2-Year Target $5.10 (-6%)

3-Year Target $4.95 (-9%)

3-Yr Target (if PE normalizes) (PE: 1→2) $5.56 (+3%)

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 22.1, Growth: -6.2%) $74.01 (+1265%)

Base: (SPY PE: 1.3, Growth: -6.2%) $4.48 (-17%)

Bear: (PE: 1.1, Growth: -6.2%) $3.81 (-30%)

💡 Upside Surprise Potential

If earnings stabilize (0% growth), PE could expand from 1.3 to 1.5

Stabilization Target: $6.09 (+12.3%)

PE Expansion Potential: +12.3%

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: May 18, 2026 5:55 AM ET
Data refreshes hourly during market hours. Next update: 6:55 AM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is BHC showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

NEUTRAL

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for BHC.

Create Free Account

Already have an account? Log In

Top Rated Drug Manufacturers - Specialty & Generic Stocks

Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
NBIX Neurocrine Biosciences I…	STRONG BUY 25 analysts	$191	63 BUY
ZTS Zoetis Inc	STRONG BUY 19 analysts	$131	57 HOLD
LNTH Lantheus Holdings Inc	STRONG BUY 13 analysts	$104	59 HOLD
AQST Aquestive Therapeutics I…	STRONG BUY 9 analysts	$9	65 BUY
BCRX BioCryst Pharmaceuticals…	STRONG BUY 12 analysts	$22	58 HOLD

NBIX Neurocrine Biosci…

63 BUY

ZTS Zoetis Inc

57 HOLD

LNTH Lantheus Holdings…

59 HOLD

AQST Aquestive Therape…

65 BUY

BCRX BioCryst Pharmace…

58 HOLD

Advanced BHC Option Strategies

Professional options setups generated by AI based on today's BHC price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for BHC

BHC Technical Chart BHC Price Prediction BHC Earnings Date BHC Investment Advisor BHC Fair Price Analyzer BHC Options Advisor BHC Options Chain BHC Options Analysis BHC Competitors

Compare BHC with Peers

BHC vs ELAN
Which one to buy?

BHC vs BLCO
Which one to buy?

BHC vs BHVN
Which one to buy?

BHC vs CPRI
Which one to buy?

BHC vs CTRA
Which one to buy?

BHC vs MTNB
Winner: BHC

Create New Comparison View All Competitors

Tradestie